Feeds
40322 items (40322 unread) in 74 feeds
Acinar Cell Carcinoma
(947 unread)
Acinic Cell Carcinoma
(353 unread)
Adenoid Cystic Carcinoma
(509 unread)
Adrenal Gland Cancer
(3507 unread)
Ampulla Of Vater
(575 unread)
Anal Cancer
(3208 unread)
Angiosarcoma
(1004 unread)
Appendix Cancer
(1264 unread)
Bile Duct Cancer
(5441 unread)
Brain and CNS
(7735 unread)
Carcinoid
(859 unread)
Endocrine/Neuroendocrine
(6661 unread)
Gall Bladder Cancer
(1824 unread)
Hemangioendothelioma
(1750 unread)
Hepatoblastoma
(545 unread)
Pancreas
(607 unread)
Phyllodes
(491 unread)
PMP and Mucinous Tumors
(396 unread)
Rhabdomyosarcoma
(1282 unread)
Sarcoma
(1364 unread)
Google - Adenoid Cystic Carcinoma (100 unread)
-
Tislelizumab by BeiGene for Head And Neck Squamous Cell ... - Pharmaceutical Technology
Posted: December 5th, 2023, 12:41am GMT
Tislelizumab by BeiGene for Head And Neck Squamous Cell ... Pharmaceutical Technology -
Uncommon but Not Elusive: A Case of Syringocystadenoma ... - Cureus
Posted: November 30th, 2023, 4:10am GMT
-
Vietnam Veteran marks holidays and birthdays at Cleveland Fisher ... - Yahoo Finance
Posted: November 28th, 2023, 4:57pm GMT
-
Write On a Houston-Made Greeting Card This Holiday Season - Houstonia Magazine
Posted: November 28th, 2023, 1:30pm GMT
Write On a Houston-Made Greeting Card This Holiday Season Houstonia Magazine -
Dancer with Rare Cancer Draws Strength from Burlesque ... - ourtownny.com
Posted: November 27th, 2023, 6:54pm GMT
-
Head and Neck Cancer: Types, Symptoms, and Treatment - Everyday Health
Posted: November 21st, 2023, 7:03pm GMT
Head and Neck Cancer: Types, Symptoms, and Treatment Everyday Health -
Primary Cutaneous Adenoid Cystic Carcinoma of the Back: A Case ... - Cureus
Posted: November 20th, 2023, 10:45am GMT
-
Primary Cutaneous Adenoid Cystic Carcinoma of the Back: A Case ... - Cureus
Posted: November 20th, 2023, 10:45am GMT
-
Toripalimab by Shanghai Junshi Biosciences for Ureter Cancer ... - Pharmaceutical Technology
Posted: November 19th, 2023, 11:58pm GMT
Toripalimab by Shanghai Junshi Biosciences for Ureter Cancer ... Pharmaceutical Technology -
AAA-614 by Clovis Oncology for Solid Tumor: Likelihood of Approval - Pharmaceutical Technology
Posted: November 18th, 2023, 1:27am GMT
AAA-614 by Clovis Oncology for Solid Tumor: Likelihood of Approval Pharmaceutical Technology -
AAA-614 by Clovis Oncology for Neuroblastoma: Likelihood of ... - Pharmaceutical Technology
Posted: November 18th, 2023, 1:27am GMT
AAA-614 by Clovis Oncology for Neuroblastoma: Likelihood of ... Pharmaceutical Technology -
Toripalimab by Shanghai Junshi Biosciences for Pleomorphic ... - Pharmaceutical Technology
Posted: November 18th, 2023, 1:01am GMT
Toripalimab by Shanghai Junshi Biosciences for Pleomorphic ... Pharmaceutical Technology -
Pembrolizumab by Merck for Sezary Syndrome: Likelihood of Approval - Pharmaceutical Technology
Posted: November 18th, 2023, 12:28am GMT
Pembrolizumab by Merck for Sezary Syndrome: Likelihood of Approval Pharmaceutical Technology -
KB-0742 Exhibits Tolerable Safety and Activity in Relapsed ... - OncLive
Posted: November 17th, 2023, 8:00pm GMT
-
Toripalimab by Shanghai Junshi Biosciences for Neuroendocrine ... - Pharmaceutical Technology
Posted: November 17th, 2023, 2:31am GMT
Toripalimab by Shanghai Junshi Biosciences for Neuroendocrine ... Pharmaceutical Technology -
Prognosis of Surgically Treated Malignant Salivary Gland Tumors - Physician's Weekly
Posted: November 16th, 2023, 4:12am GMT
Prognosis of Surgically Treated Malignant Salivary Gland Tumors Physician's Weekly -
Gretchen Lautzenheiser Obituary - Oakley-Hammond Funeral Home ... - Legacy.com
Posted: November 15th, 2023, 6:28pm GMT
-
Tigilanol tiglate by QBiotics Group for Metastatic Colorectal Cancer ... - Pharmaceutical Technology
Posted: November 15th, 2023, 8:30am GMT
Tigilanol tiglate by QBiotics Group for Metastatic Colorectal Cancer ... Pharmaceutical Technology -
Regorafenib by Bayer for Glioblastoma Multiforme (GBM ... - Pharmaceutical Technology
Posted: November 15th, 2023, 6:00am GMT
Regorafenib by Bayer for Glioblastoma Multiforme (GBM ... Pharmaceutical Technology -
A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth ... - Cancer Discovery
Posted: November 14th, 2023, 6:26am GMT
-
ABCB1 and immune genes in breast cancer | BCTT - Dove Medical Press
Posted: November 13th, 2023, 12:48am GMT
ABCB1 and immune genes in breast cancer | BCTT Dove Medical Press -
Cabometyx by Exelixis for Esophageal Squamous Cell Carcinoma ... - Pharmaceutical Technology
Posted: November 8th, 2023, 6:00am GMT
Cabometyx by Exelixis for Esophageal Squamous Cell Carcinoma ... Pharmaceutical Technology -
Bilateral Dacryoadenitis As the First Presentation in an ... - Cureus
Posted: November 5th, 2023, 5:29am GMT
-
Bilateral Dacryoadenitis As the First Presentation in an ... - Cureus
Posted: November 5th, 2023, 5:29am GMT
-
Cabometyx by Exelixis for Laryngeal Cancer: Likelihood of Approval - Pharmaceutical Technology
Posted: November 5th, 2023, 5:00am GMT
Cabometyx by Exelixis for Laryngeal Cancer: Likelihood of Approval Pharmaceutical Technology -
Gotistobart by OncoC4 for Solid Tumor: Likelihood of Approval - Pharmaceutical Technology
Posted: November 4th, 2023, 2:16am GMT
Gotistobart by OncoC4 for Solid Tumor: Likelihood of Approval Pharmaceutical Technology -
Gotistobart by OncoC4 for Solid Tumor: Likelihood of Approval - Pharmaceutical Technology
Posted: November 4th, 2023, 2:16am GMT
Gotistobart by OncoC4 for Solid Tumor: Likelihood of Approval Pharmaceutical Technology -
Pembrolizumab by Merck for Thyroid Cancer: Likelihood of Approval - Pharmaceutical Technology
Posted: November 4th, 2023, 1:48am GMT
Pembrolizumab by Merck for Thyroid Cancer: Likelihood of Approval Pharmaceutical Technology -
Risk Adjusted Net Present Value: What is the current valuation of ... - Pharmaceutical Technology
Posted: November 4th, 2023, 12:46am GMT
Risk Adjusted Net Present Value: What is the current valuation of ... Pharmaceutical Technology -
An Unusual Finding of a Neurogenic Tumor of the Trachea: A ... - Cureus
Posted: November 2nd, 2023, 3:01pm GMT
-
Unusual Presentation of Primary Hyper-IgE-related Salivary Gland ... - Cureus
Posted: November 1st, 2023, 4:58am GMT
-
Novel B7-H4 Targeted ADCs Generate Activity and Show ... - OncLive
Posted: October 31st, 2023, 6:05pm GMT
-
How to perform prespecified subgroup analyses when using ... - BMC Medical Research Methodology
Posted: October 31st, 2023, 3:53am GMT
How to perform prespecified subgroup analyses when using ... BMC Medical Research Methodology -
News - Triumph Over Adversity - DVIDS
Posted: October 30th, 2023, 1:47pm GMT
-
Triumph Over Adversity > Sixteenth Air Force (Air Forces Cyber ... - 16af.af.mil
Posted: October 30th, 2023, 1:39pm GMT
-
Risk Adjusted Net Present Value: What is the current valuation of ... - Pharmaceutical Technology
Posted: October 28th, 2023, 1:26am GMT
Risk Adjusted Net Present Value: What is the current valuation of ... Pharmaceutical Technology -
Regorafenib by Bayer for Pancreatic Ductal Adenocarcinoma ... - Pharmaceutical Technology
Posted: October 27th, 2023, 2:34pm GMT
Regorafenib by Bayer for Pancreatic Ductal Adenocarcinoma ... Pharmaceutical Technology -
Early Trials of PRMT5 Inhibitors Leave Much to Be Desired, But ... - OncLive
Posted: October 27th, 2023, 11:14am GMT
-
ANV-419 by Anaveon for Non-Small Cell Lung Cancer: Likelihood of ... - Pharmaceutical Technology
Posted: October 27th, 2023, 5:00am GMT
ANV-419 by Anaveon for Non-Small Cell Lung Cancer: Likelihood of ... Pharmaceutical Technology -
Dovitinib lactate by Allarity Therapeutics for Solid Tumor: Likelihood ... - Pharmaceutical Technology
Posted: October 26th, 2023, 5:00am GMT
Dovitinib lactate by Allarity Therapeutics for Solid Tumor: Likelihood ... Pharmaceutical Technology -
Apatinib mesylate by Elevar Therapeutics for Breast Cancer ... - Pharmaceutical Technology
Posted: October 26th, 2023, 5:00am GMT
Apatinib mesylate by Elevar Therapeutics for Breast Cancer ... Pharmaceutical Technology -
Dovitinib lactate by Allarity Therapeutics for Metastatic Ovarian ... - Pharmaceutical Technology
Posted: October 26th, 2023, 5:00am GMT
Dovitinib lactate by Allarity Therapeutics for Metastatic Ovarian ... Pharmaceutical Technology -
Apatinib mesylate by Elevar Therapeutics for Synovial Sarcoma ... - Pharmaceutical Technology
Posted: October 26th, 2023, 5:00am GMT
Apatinib mesylate by Elevar Therapeutics for Synovial Sarcoma ... Pharmaceutical Technology -
Regorafenib by Bayer for Glioblastoma Multiforme (GBM ... - Pharmaceutical Technology
Posted: October 26th, 2023, 5:00am GMT
Regorafenib by Bayer for Glioblastoma Multiforme (GBM ... Pharmaceutical Technology -
NCT/DKFZ MASTER handbook of interpreting whole-genome ... - Nature.com
Posted: October 26th, 2023, 5:00am GMT
-
Immunologists aim to explore new avenues for immunotherapy of ... - News-Medical.Net
Posted: October 26th, 2023, 5:00am GMT
Immunologists aim to explore new avenues for immunotherapy of ... News-Medical.Net -
Tislelizumab by BeiGene for Adenoid Cystic Carcinoma (ACC ... - Pharmaceutical Technology
Posted: October 26th, 2023, 12:20am GMT
Tislelizumab by BeiGene for Adenoid Cystic Carcinoma (ACC ... Pharmaceutical Technology -
Tislelizumab by BeiGene for Cervical Cancer: Likelihood of Approval - Pharmaceutical Technology
Posted: October 26th, 2023, 12:14am GMT
Tislelizumab by BeiGene for Cervical Cancer: Likelihood of Approval Pharmaceutical Technology -
Elevar shells out $600M for rights to Hengrui's anti-PD-1 antibody ... - BioWorld Online
Posted: October 24th, 2023, 2:00pm GMT
-
Ovarian Clear Cell Carcinoma with Recurrent Endometriosis | IJWH - Dove Medical Press
Posted: October 24th, 2023, 6:25am GMT
Ovarian Clear Cell Carcinoma with Recurrent Endometriosis | IJWH Dove Medical Press -
Luspatercept Approval Shifts Treatment Landscape of Anemia in ... - OncLive
Posted: October 24th, 2023, 5:00am GMT
-
Keytruda wins second place in the race to approval for neo-adjuvant ... - Clinical Trials Arena
Posted: October 23rd, 2023, 5:00am GMT
Keytruda wins second place in the race to approval for neo-adjuvant ... Clinical Trials Arena -
FDA Expands Entrectinib Indication in Pediatric Patients With ... - OncLive
Posted: October 20th, 2023, 5:00am GMT
-
Elevar shells out $600M for rights to Hengrui's anti-PD-1 antibody ... - BioWorld Online
Posted: October 19th, 2023, 7:14pm GMT
-
Clinical Research Demonstrates Positive Impact of Genomic Testing ... - OncLive
Posted: October 19th, 2023, 5:00am GMT
-
BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave ... - Fred Hutchinson Cancer Center
Posted: October 17th, 2023, 5:00am GMT
BRCA-mutation researcher Dr. Rosevalentine Bosire named Brave ... Fred Hutchinson Cancer Center -
MSD’s Keytruda expands reach in lung cancer with neoadjuvant ... - Pharmaceutical Technology
Posted: October 17th, 2023, 5:00am GMT
MSD’s Keytruda expands reach in lung cancer with neoadjuvant ... Pharmaceutical Technology -
Deciphering the Pathways to PARP Sensitivity in Pancreatic Cancer - Cancer Discovery
Posted: October 13th, 2023, 10:55am GMT
Deciphering the Pathways to PARP Sensitivity in Pancreatic Cancer Cancer Discovery -
Lirafugratinib Elicits Durable Responses Across Several FGFR2+ ... - OncLive
Posted: October 13th, 2023, 5:00am GMT
-
Raphael Bosse, MD, PhD Joins Naples-Goodlette - OncLive
Posted: October 13th, 2023, 5:00am GMT
-
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma ... - Cancer Discovery
Posted: October 12th, 2023, 11:29am GMT
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma ... Cancer Discovery -
A Rare Case of Recurrent Carcinoma Ex Basal Cell Adenoma of the ... - Cureus
Posted: October 12th, 2023, 8:55am GMT
-
A Rare Case of Recurrent Carcinoma Ex Basal Cell Adenoma of the ... - Cureus
Posted: October 12th, 2023, 8:55am GMT
-
Ongoing Research Could Add to Atezolizumab/Bevacizumab ... - OncLive
Posted: October 12th, 2023, 5:00am GMT
-
Global variations in lung cancer incidence by histological subtype in ... - The Lancet
Posted: October 11th, 2023, 8:33pm GMT
-
Antidepressants After Diagnosis of Liver Cancer May Lower ... - Curetoday.com
Posted: October 11th, 2023, 1:55pm GMT
-
FDA Approves Encorafenib Plus Binimetinib for BRAF V600E+ ... - OncLive
Posted: October 11th, 2023, 5:00am GMT
-
FDA Approves FoundationOne CDx Companion Diagnostic for ... - OncLive
Posted: October 10th, 2023, 5:00am GMT
-
Tracheal Papilloma Mimicking Severe Asthma | Article - Cureus
Posted: October 9th, 2023, 12:43pm GMT
-
Tracheal Papilloma Mimicking Severe Asthma | Article - Cureus
Posted: October 9th, 2023, 12:43pm GMT
-
SGNB-7H4V by Seagen for Adenoid Cystic Carcinoma (ACC ... - Pharmaceutical Technology
Posted: October 9th, 2023, 5:00am GMT
SGNB-7H4V by Seagen for Adenoid Cystic Carcinoma (ACC ... Pharmaceutical Technology -
Toripalimab by Coherus BioSciences for Nasopharyngeal Cancer ... - Pharmaceutical Technology
Posted: October 9th, 2023, 5:00am GMT
Toripalimab by Coherus BioSciences for Nasopharyngeal Cancer ... Pharmaceutical Technology -
IDE-397 by Ideaya Biosciences for Squamous Non-Small Cell Lung ... - Pharmaceutical Technology
Posted: October 9th, 2023, 5:00am GMT
IDE-397 by Ideaya Biosciences for Squamous Non-Small Cell Lung ... Pharmaceutical Technology -
Margaret Davis wins national volunteer award - Lake Cowichan Gazette
Posted: October 9th, 2023, 3:19am GMT
Margaret Davis wins national volunteer award Lake Cowichan Gazette -
The Arsenal of Metastatic Breast Cancer Imaging Modalities ... - OncLive
Posted: October 6th, 2023, 5:00am GMT
-
Florida Cancer Specialists & Research Institute Welcomes Bahaa ... - OncLive
Posted: October 6th, 2023, 5:00am GMT
-
William (Bill) Neff III Obituary - 2023 - Legacy.com
Posted: October 6th, 2023, 10:22pm GMT
William (Bill) Neff III Obituary - 2023 Legacy.com -
Time to Think about HLA-Based Diagnostics in Lung Cancer? - Cancer Discovery
Posted: October 5th, 2023, 7:58pm GMT
Time to Think about HLA-Based Diagnostics in Lung Cancer? Cancer Discovery -
Spectrum of Mucin-containing Lesions of the Breast: Multimodality ... - RSNA Publications Online
Posted: October 4th, 2023, 3:05pm GMT
Spectrum of Mucin-containing Lesions of the Breast: Multimodality ... RSNA Publications Online -
Triple-Negative Breast Cancer: Histopathologic Features, Genomics ... - RSNA Publications Online
Posted: October 4th, 2023, 3:05pm GMT
Triple-Negative Breast Cancer: Histopathologic Features, Genomics ... RSNA Publications Online -
Symptom: Left-Sided Ear Drainage : The Hearing Journal - LWW Journals
Posted: October 4th, 2023, 12:25pm GMT
-
A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth ... - Cancer Discovery
Posted: October 3rd, 2023, 12:01pm GMT
-
Clinical characteristics, radiologic features, and histopathology of ... - Nature.com
Posted: October 3rd, 2023, 9:30am GMT
-
Multiple Myeloma Call-to-Action Plan Seeks to Ignite Widespread ... - OncLive
Posted: October 3rd, 2023, 5:00am GMT
-
Woman admits being high when pickup left street, killing former U athlete - Yahoo News
Posted: October 3rd, 2023, 5:00am GMT
-
Woman admits being high when her speeding pickup left street ... - Star Tribune
Posted: October 2nd, 2023, 8:04pm GMT
-
Nail Changes in a Patient With Cancer - Mayo Clinic Proceedings
Posted: October 2nd, 2023, 2:23pm GMT
Nail Changes in a Patient With Cancer Mayo Clinic Proceedings -
CD4+ TIL to the Rescue of Anti–PD-1 Failure by Targeting MHC-II - Cancer Discovery
Posted: October 2nd, 2023, 5:30am GMT
CD4+ TIL to the Rescue of Anti–PD-1 Failure by Targeting MHC-II Cancer Discovery -
FDA Grants Marketing Authorization to First DNA Test to Assess ... - OncLive
Posted: October 2nd, 2023, 5:00am GMT
-
Revumenib Meets CR/CRh End Point in KMT2A-Rearranged ... - OncLive
Posted: October 2nd, 2023, 5:00am GMT
-
Ono, Adimab partner to develop oncology antibody drugs - Pharmaceutical Technology
Posted: September 28th, 2023, 5:00am GMT
Ono, Adimab partner to develop oncology antibody drugs Pharmaceutical Technology -
Gilead Discontinues Phase 3 ENHANCE-2 Trial of Magrolimab Plus ... - OncLive
Posted: September 27th, 2023, 5:00am GMT
-
C-kit receptors as a therapeutic target in cancer | OTT - Dove Medical Press
Posted: September 27th, 2023, 2:03am GMT
C-kit receptors as a therapeutic target in cancer | OTT Dove Medical Press -
Gorlin-Goltz Syndrome: A Case Series | Article - Cureus
Posted: September 21st, 2023, 5:00am GMT
-
Gorlin-Goltz Syndrome: A Case Series | Article - Cureus
Posted: September 21st, 2023, 5:00am GMT
-
Study suggests poor oral health could lessen survival from head and neck cancer - Medical Xpress
Posted: September 19th, 2023, 5:00am GMT
-
Dr Johnson on the Initial Efficacy of Ifinatamab Deruxtecan in ... - OncLive
Posted: September 18th, 2023, 5:00am GMT
-
Phase 1 Study of JNJ-64619178, a Protein Arginine ... - Cancer Discovery
Posted: September 15th, 2023, 6:21am GMT
Phase 1 Study of JNJ-64619178, a Protein Arginine ... Cancer Discovery -
Abstract PO-092: Molecular characterization of the salivary adenoid ... - Cancer Discovery
Posted: September 15th, 2023, 5:34am GMT
-
Palatal Swelling: Exploring an Elusive Diagnostic Dilemma - Cureus
Posted: September 14th, 2023, 5:08pm GMT